C., Hicklin, D
Collectively, these recent contributions argue that future GSH-centric redox sensing and nanomedical approaches should (i) incorporate organelle targeting (especially mitochondria) to exploit subcellular redox heterogeneity, (ii) embed analyte-responsive activation into both therapeutic and imaging components, (iii) combine biochemical sensing with optical or thermal engineering for spatiotemporal control, and (iv) favor clinically translatable carriers (e.g., PLGA) for delivery
At Kizer Pharmacy, our team helps patients navigate peptide therapy with guidance and pharmacist-reviewed options
F., 2nd, Parke, C., Brown, J., Barris, L
It pairs especially well with Rho's Liposomal NAD+ for a combined cellular energy and detox stack
Ferroptosis-regulated cell death as a therapeutic strategy for neurodegenerative diseases: current status and future prospects